Photodynamic therapy for obstructive esophageal malignancies

Area of Science:

• Oncology
• Gastroenterology
• Medical Technology

Background:

• Obstructive esophageal cancer presents significant challenges for patients ineligible for conventional treatments.
• Photodynamic therapy (PDT) is an alternative therapeutic modality for managing esophageal malignancies.

Purpose of the Study:

• To evaluate the factors influencing survival, benefits, and complications in patients with obstructive esophageal cancer treated with PDT.
• To assess the efficacy of PDT in improving esophageal patency and palliation.

Main Methods:

• A cohort of 140 patients with obstructive adeno or squamous cell carcinoma received PDT between 1982 and 1998.
• Multivariate analysis was employed to determine the impact of clinical stage, Karnofsky Performance Status (KPS), and other variables on survival.
• Esophageal diameter, tumor characteristics, and complication data were systematically recorded.

Main Results:

• Clinical stage was the sole significant predictor of survival, with median survival rates varying from 56 months (Stage I) to 3.5 months (Stage IV).
• Karnofsky Performance Status (KPS) >/= 70 demonstrated a statistically significant positive impact on survival for Stages III and IV.
• PDT significantly increased the mean minimum esophageal diameter from 6.2 mm to 11.1 mm, relieving complete obstruction.

Conclusions:

• Photodynamic therapy is associated with minimal complications and mortality in esophageal cancer treatment.
• PDT effectively relieves complete esophageal obstruction and provides palliation comparable or superior to other regimens for non-curative cases.